1994 J . Org. Chem., Vol. 65, No. 7, 2000
Ojea et al.
precipitate immediately formed was filtered, dried, and puri-
fied by reversed-phase flash chromatography, eluting with
water to give (+)-6a (236 mg, 94%) as a colorless solid: mp
155.7 (CO), 171.3 (CO); 31P NMR (CDCl3) δ 31.17; FABMS m/z
382 (MH+, 17), 326 ([M - C4H8]H+, 10), 282 ([M - C5H9O2]-
H+, 100).
(EtOH) > 80 °C (dec); Rf 1.0 (RP-18, H2O); [R]20 ) +33.8 (c
D
(4S,5R)-5-[N-(ter t-Bu toxyca r bon yl)a m in o]-2-eth oxy-4-
m eth yl-2-oxo-1,2-oxa p h osp h or in a n e (15a ). Over a cooled
suspension (0 °C) of LiBH4 (214 mg, 9.83 mmol) in 70 mL of
dry THF was added dropwise a solution of 14a (2.5 g, 6.56
mmoL) in 20 mL of THF, and the resulting mixture was stirred
for 16 h at room temperature. Then, the reaction mixture was
cooled to 0 °C, and HCl 2 N was added to reach pH ) 7. THF
was evaporated and the aqueous phase extracted with AcOEt,
dried (Na2SO4), and evaporated. The crude material was
purified by flash chromatography (silica gel, AcOEt/hexane 3:1
to AcOEt) to give 1.41 g (73%) of 15a as a colorless solid: mp
(AcOEt) 121-124 °C; Rf 0.34 (silica gel, AcOEt/hexane 3:1);
1.0, H2O); IR (KBr) ν 3430 (OH), 2976 (NH2), 1727 (CdO), 1257
(CO), 1122 (PdO), 1040, 931 (POH) cm-1 1H NMR (D2O) δ
;
1.16 (d, J ) 6.8 Hz, 3H, CH3), 1.77 (ddd, J ) 18.1, 15.3, 9.1
Hz, 1H, H-4), 1.82 (ddd, J ) 19.2, 15.3, 6.1 Hz, 1H, H-4), 2.45-
2.58 (m, 1H, H-3), 4.08 (d, 3.6 Hz, 1H, H-2); 13C NMR (D2O) δ
18.7 (J ) 6.4 Hz, CH3), 33.1 (C-3), 33.8 (J ) 128.8 Hz, C-4),
61.0 (J ) 12.8 Hz, C-2), 174.3 (CO); 31P NMR (D2O) δ 23.80;
FABMS m/z 198 (MH+, 100), 152 ([M - CO2]H+, 18).
(2R,3S)-2-Am in o-3-m eth yl-4-p h osp h on obu ta n oic a cid
((-)-6a ) was prepared following the same procedure, starting
from 620 mg of amino ester (-)-12a to yield 378 mg (89%) of
a colorless solid: [R]22 ) -34.2 (c 1.0, H2O).
[R]20 ) +74.8 (c 1.0, CH2Cl2); IR (KBr) ν 3285 (NH), 1701
D
D
(CdO), 1279 (PdO) cm-1 1H NMR (CDCl3) δ 1.05 (dd, J )
;
(2S,3S)-2-Am in o-3-m eth yl-4-p h osp h on obu ta n oic Acid
((+)-6b). Amino acid (+)-6b was prepared following the same
procedure as described above for the 2,3-anti-amino acids 6a ,
starting from 500 mg of amino ester (+)-12b to yield 321 mg
(91%) of a colorless solid: mp (EtOH) > 80 °C (dec); Rf 1.0
6.7, 3.4 Hz, 3H, CHCH3), 1.36 (t, J ) 7.1 Hz, 3H, OCH2CH3),
1.44 (s, 9H, C(CH3)3), 1.65 (ddd, J ) 15.4, 13.1 Hz, 1H, H-3),
1.85 (ddd, J ) 19.1, 15.4, 4.1 Hz, 1H, H-3), 2.22-2.37 (m, 1H,
H-4), 3.80 (brd, J ) 9.4 Hz, 1H, H-5), 4.08-4.23 (m, 4H, OCH2),
5.20 (brd, J ) 9.4 Hz, 1H, NH); 13C NMR (CDCl3) δ 16.4 (J )
5.8 Hz, OCH2CH3), 19.7 (J ) 18.8 Hz, CHCH3), 26.4 (J ) 125.9
Hz, C-3), 28.3 (C(CH3)3), 33.4 (J ) 6.5 Hz, C-4), 49.5 (J ) 4.1
Hz, C-5), 61.1 (J ) 6.5 Hz, POCH2), 72.7 (J ) 6.8 Hz, C-6),
77.0 (C(CH3)3) 155.3 (CO); 31P NMR (CDCl3) δ 23.35; FABMS
m/z 294 (MH+, 15), 238 ([M - C4H8]H+, 60), 194 ([M - C5H9O2]-
H+, 100).
(RP-18, H2O); [R]20 ) +14.2 (c 1.0, H2O); IR (KBr) ν 3441
D
(OH), 3275 (NH2), 1733 (CdO), 1257 (C-O), 1030, 920 (POH)
cm-1 1H NMR (D2O) δ 1.15 (d, J ) 7.1 Hz, 3H, CH3), 1.74
;
(ddd, J ) 18.5, 15.3, 7.8 Hz, 1H, H-4), 1.87 (ddd, J ) 18.7,
15.3, 6.1 Hz, 1H, H-4), 2.55-2.70 (m, 1H, H-3), 4.08 (d, J )
3.4 Hz, 1H, H-2); 13C NMR (D2O) δ 18.6 (J ) 6.4 Hz, CH3),
32.9 (C-3), 33.7 (J ) 132.5 Hz, C-4), 61.2 (J ) 6.0 Hz, C-2),
174.7 (CO); 31P NMR (D2O) δ 23.80; FABMS m/z 198 (MH+,
100), 152 ([M - CO2]H+, 25).
(4R,5R)-5-[N-(ter t-Bu toxyca r bon yl)a m in o]-2-eth oxy-4-
m eth yl-2-oxo-1,2-oxa p h osp h or in a n e (15b) was prepared
following the same procedure as described above for 15a ,
starting from 1.1 g of N-Boc-amino ester 14b, to yield 621 mg
(73%) of a colorless oil (2 diastereoisomers, 2.7:1): Rf 0.35
(silica gel, AcOEt/hexane 3:1); IR (film) ν 3260 (NH), 1713
(CdO), 1271 (PdO) cm-1; 1H NMR (CDCl3) δ (signals for major
diastereoisomer): 1.12 (dd, J ) 6.5, 3.5 Hz, 3H), 1.35 (t, 7.1
Hz, 3H), 1.44 (s, 9H), 1.56-1.69 (m, 1H), 1.98-2.08 (m, 2H),
3.45-3.59 (m, 1H), 3.76 (dt, J ) 10.7, 3.8 Hz, 1H), 4.10-4.31
(m, 3H), 4.40 (brd, 1H); 31P NMR (CDCl3) δ 23.95 (major), 25.78
(minor); FABMS m/z 294 (MH+, 14), 238 ([M - C4H8]H+, 60),
194 ([M - C5H9O2]H+, 100).
(2R,3R)-2-Am in o-3-m eth yl-4-p h osp h on obu ta n oic a cid
((-)-6b) was prepared following the same procedure, starting
from 600 mg of amino ester (-)-12b to yield 389 mg (92%) of
a colorless solid: [R]20 ) -13.9 (c 1.0, H2O).
D
Eth yl (2R,3S)-2-[N-(ter t-Bu toxyca r bon yl)a m in o]-4-d i-
eth oxyp h osp h or yl-3-m eth ylbu ta n oa te (14a ). A solution of
the amino ester (-)-12a (2.0 g, 7.1 mmol), Na2CO3 (566 mg,
5.34 mmol), and NaHCO3 (532 mg, 6.34 mmol) in 50 mL of
dioxane and 50 mL of H2O at 0 °C was treated with Boc2O
(1.8 g, 8.31 mmol). The mixture was stirred at room temper-
ature for 1 h, after which time it was concentrated to half its
initial volume and extracted with CH2Cl2. The combined
organic layers were dried (Na2SO4) and concentrated in vacuo.
The crude material was purified by flash chromatography
(silica gel, AcOEt/hexane 3:1 to AcOEt) to give 2.57 g (95%) of
14a as a colorless oil: Rf 0.38 (silica gel, AcOEt/hexane 3:1);
(4S,5R)-5-Am in o-2-h ydr oxy-4-m eth yl-2-oxo-1,2-oxaph os-
p h or in a n e (13a ). BrTMS (0.32 mL, 2.45 mmol) was added
dropwise over a cooled (0 °C) solution of 15a (300 mg, 1.02
mmol) in 6 mL of dry CH2Cl2, and the mixture was stirred for
12 h. The reaction was quenched with MeOH, and the solvent
was removed in vacuo. The crude material was purified by
reversed-phase flash chromatography eluting with water to
give 204 mg (82%) of HBr.13a as a colorless solid: Rf 0.90 (RP-
[R]20 ) -12.9 (c 1.0, CH2Cl2); IR (film) ν 3276 (NH), 2981,
D
2935 (CH), 1745, 1714 (CdO), 1250 (CO), 1167 (PdO) cm-1
;
1H NMR (CDCl3) δ 1.13 (d, J ) 6.9 Hz, 3H), 1.23-1.35 (m,
9H), 1.44 (s, 9H), 1.61 (ddd, J ) 18.2, 15.3, 10.1 Hz, 1H), 1.86
(ddd, J ) 20.6, 15.3, 2.9 Hz, 1H), 2.32-2.46 (m, 1H), 4.06-
4.24 (m, 7H), 5.40 (brd, J ) 8.0 Hz, 1H); 13C NMR (CDCl3) δ
14.2 (CH3), 16.4 (J ) 5.9 Hz, CH3), 17.4 (CH3), 28.3 (CH3), 28.6
(J ) 141.4 Hz, CH2), 31.9 (CH), 58.6 (J ) 16.0 Hz, CH), 61.4
(CH2), 61.5 (J ) 6.4 Hz, POCH2), 61.7 (J ) 6.4 Hz, POCH2),
79.9 (C), 155.3 (CO), 171.0 (CO); 31P NMR (CDCl3) δ 30.92;
FABMS m/z 382 (MH+, 36), 326 ([M - C4H8]H+, 29), 282 ([M
- C5H9O2]H+, 100).
18, H2O); [R]20 ) +35.6 (c 1.2, H2O); IR (film) ν 2906 (NH3+),
D
1262 (PdO), 969 (POH) cm-1; 1H NMR (400 MHz, D2O) δ 1.16
(dd, J ) 7.4, 2.9 Hz, 3H, CH3), 1.61 (dt, J ) 15.3, 13.6 Hz, 1H,
H-3), 1.87 (ddd, J ) 18.0, 15.3, 4.4 Hz, 1H, H-3), 2.48-2.60
(m, 1H, H-4), 3.48-3.52 (m, 1H, H-5), 4.25 (ddd, J ) 20.6, 13.6,
2.2 Hz, 1H, H-6), 4.23 (ddd, J ) 13.6, 5.1, 2.2 Hz, 1H, H-6);
13C NMR (DMSO-d6) δ 18.9 (J ) 16.0 Hz, CH3), 26.7 (J ) 123.0
Hz, C-3), 30.7 (J ) 6.1 Hz, C-4), 50.1 (J ) 4.3 Hz, C-5), 67.9 (J
) 5.8 Hz, C-6); 31P NMR (CDCl3) δ 20.73; FABMS m/z 166
(MH+, 100).
Eth yl (2R,3R)-2-[N-(ter t-Bu toxyca r bon yl)a m in o]-4-d i-
eth oxyp h osp h or yl-3-m eth ylbu ta n oa te (14b). Prepared fol-
lowing the same procedure as described above for 14a , starting
from 1.0 g of amino ester (-)-12b. Purification by flash
chromatography (silica gel, AcOEt/hexane 3:1 to AcOEt)
afforded 1.29 g (96%) of 14b as a colorless oil: Rf 0.38 (silica
gel, AcOEt/hexane 3:1); [R]20D ) -20.2 (c 0.9, CH2Cl2); IR (film)
ν 3265 (NH), 2980, 2935 (CH), 1745, 1714 (CdO), 1250 (CdO),
1164 (PdO) cm-1; 1H NMR (CDCl3) δ 1.02 (d, J ) 6.9 Hz, 3H),
1.27-1.35 (m, 9H), 1.44 (s, 9H), 1.58 (ddd, J ) 17.3, 15.5, 9.6
Hz, 1H), 2.00 (ddd, J ) 19.5, 15.5, 3.8 Hz, 1H), 2.50-2.60 (m,
1H), 4.05-4.24 (m, 6H), 4.37 (brd, 1H), 5.20 (brd, J ) 8.1 Hz,
1H); 13C NMR (CDCl3) δ 14.2 (CH3), 15.8 (J ) 4.8 Hz, CH3),
16.4 (J ) 6.0 Hz, CH3), 28.3 (CH3), 29.3 (J ) 141.0 Hz, CH2),
31.4 (J ) 2.3 Hz, CH), 58.2 (J ) 15.9 Hz, CH), 61.4 (OCH2),
61.5 (J ) 6.8 Hz, POCH2), 61.6 (J ) 6.8 Hz, POCH2), 79.9 (C),
(4R,5R)-5-Am in o-2-h ydr oxy-4-m eth yl-2-oxo-1,2-oxaph os-
p h or in a n e (13b). Prepared following the same procedure as
described above for 13a , starting from 300 mg of N-Boc-amino
ester 15b to yield 211 mg (84%) of a colorless solid: mp > 200
°C (dec); Rf 0.90 (RP-18, H2O); [R]20 ) +7.6 (c 0.95, H2O); IR
D
(KBr) ν 3035 (NH3+), 1256, 1236 (PdO), 991 (POH) cm-1; H
1
NMR (400 MHz, D2O) δ 1.20 (dd, J ) 7.4, 2.2 Hz, 3H, CH3),
1.61 (dt, J ) 10.8, 15.1 Hz, 1H, H-3ax), 1.97 (ddd, J ) 17.0,
15.1, 4.0 Hz, 1H, H-3ec), 2.22-2.38 (m, 1H, H-4), 3.24 (dt, J )
3.2, 9.1 Hz, 1H, H-5), 4.10 (dt, J ) 15.4, 9.1 Hz, 1H, H-6ax),
4.35 (ddd, J ) 15.4, 11.8, 3.2 Hz, 1H, H-6ec); 13C NMR (DMSO-
d6) δ 19.1 (J ) 14.2 Hz, CH3), 28.2 (J ) 124.9 Hz, C-3), 31.7 (J
) 6.2 Hz, C-4), 51.3 (J ) 4.8 Hz, C-5), 65.7 (J ) 5.6 Hz, C-6);
31P NMR (CDCl3) δ 21.44; FABMS m/z 166 (MH+, 100).